InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc. (ticker: INM) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of INM's SEC filings surfaces 4 active risk signals, including 2 late-filing signals, and 2 auditor-change signals. INM reported $1.94M in revenue and -$6.72M for the period ending 2025-12-31, with operating cash flow of -$5.68M. Cash and equivalents stood at $5.16M (up 10.2% year-over-year). Total assets of $9.13M exceed total liabilities of $2.24M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.